+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Botulinum Toxins in Dermatology & Cosmetology Market by Product Type, Therapeutic Indication, End User, Distribution Channel, Route Of Administration - Global Forecast to 2030- Product Image
Botulinum Toxins in Dermatology & Cosmetology Market by Product Type, Therapeutic Indication, End User, Distribution Channel, Route Of Administration - Global Forecast to 2030- Product Image
Sale

Botulinum Toxins in Dermatology & Cosmetology Market by Product Type, Therapeutic Indication, End User, Distribution Channel, Route Of Administration - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081292
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The botulinum toxin market is at a pivotal point, driven by growing demand for advanced, minimally invasive cosmetic and therapeutic treatments. Evolving patient expectations and regulatory frameworks are reshaping clinical delivery, while global and regional dynamics introduce both opportunities and fresh complexities for leaders in the field.

Market Snapshot: Botulinum Toxin Market Growth and Outlook

This market is experiencing significant momentum, with robust healthcare infrastructure, evolving patient needs, and ongoing innovations in neurotoxin technology underpinning its trajectory. Market size and growth rates are bolstered by widespread clinical adoption for both aesthetic and therapeutic uses, while competitive differentiation is increasingly shaped by strategic operational choices.

Scope & Segmentation

  • Product Categories: Botulinum Toxin Type A (AbobotulinumtoxinA/Dysport, IncobotulinumtoxinA/Xeomin, LetibotulinumtoxinA, OnabotulinumtoxinA/Botox, PrabotulinumtoxinA/Jeuveau), Botulinum Toxin Type B (RimabotulinumtoxinB/Myobloc)
  • Therapeutic Indications: Crow's feet, forehead lines, glabellar lines, hyperhidrosis
  • End Users: Ambulatory surgical centers, dermatology clinics, hospitals, medical spas
  • Distribution Channels: Direct sales, hospital pharmacies, online pharmacies, retail pharmacies
  • Routes of Administration: Intradermal injection, intramuscular injection, subcutaneous injection
  • Regional Coverage: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: AbbVie Inc., Ipsen S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Daewoong Pharmaceutical Co., Ltd., Evolus, Inc., Medytox, Inc., Revance Therapeutics, Inc., HUGEL, Inc., Lanzhou Institute of Biological Products

Key Takeaways for Senior Decision-Makers

  • Patient demand is rapidly shifting towards precision-based, minimally invasive interventions, requiring companies to adapt through continuous innovation and robust training programs.
  • Expanded product variants and novel administration routes are increasing the versatility and scope of botulinum toxin applications in both medical and cosmetic fields.
  • Regional dynamics play a critical role, with Asia-Pacific emerging as a primary growth area due to rising middle-class populations and increased access to specialized treatments.
  • Competitive landscapes favor manufacturers and service providers with diversified product portfolios and local manufacturing or multi-source supply chains.
  • Digital platforms and telehealth are transforming engagement models, emphasizing the need for data-driven strategies and seamless patient experiences.
  • Collaborations across academia and industry are accelerating knowledge transfer and unlocking new markets, especially where regulatory and reimbursement structures are evolving.

Tariff Impact on the Botulinum Toxin Market

Recent U.S. tariff legislation has increased costs on imported neurotoxin formulations and devices, driving companies to consider onshore production or diversified sourcing. These changes are recalibrating regional competitiveness, prompting businesses to reassess supply chain resiliency and pricing strategies. Stakeholder advocacy efforts are underway aiming for potential exemptions on products critical to health and wellbeing. For now, operational flexibility and transparent communication remain essential in mitigating supply chain disruptions linked to these tariffs.

Methodology & Data Sources

Research findings rely on in-depth interviews with dermatology and cosmetic surgery experts, supplemented by roundtables and advisory panels. Comprehensive secondary research incorporates peer-reviewed journals, regulatory data, company disclosures, industry reports, and robust statistical analysis of historical transaction data. All information is validated to ensure impartiality and codependence with current market realities.

Why This Report Matters

  • Strategic guidance enables stakeholders to proactively address market shifts and innovate product portfolios to capture new opportunities.
  • Segment-level analysis supports effective investment decisions, helping target growth areas aligned with both consumer and regulatory developments.
  • Detailed competitive and regional intelligence empowers leaders to refine supply chain, marketing, and clinical strategies for sustained success.

Conclusion

The botulinum toxin market is set for sustained evolution, marked by ongoing innovation, responsive operational strategies, and regional differentiation. Decision-makers positioned to capitalize on technology, flexible sourcing, and data-driven insights will be best placed to drive long-term growth in both established and emerging markets.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Botulinum Toxins in Dermatology & Cosmetology Market, by Product Type
8.1. Introduction
8.2. Botulinum Toxin Type A
8.2.1. AbobotulinumtoxinA (Dysport)
8.2.2. IncobotulinumtoxinA (Xeomin)
8.2.3. LetibotulinumtoxinA
8.2.4. OnabotulinumtoxinA (Botox)
8.2.5. PrabotulinumtoxinA (Jeuveau)
8.3. Botulinum Toxin Type B
8.3.1. RimabotulinumtoxinB (Myobloc)
9. Botulinum Toxins in Dermatology & Cosmetology Market, by Therapeutic Indication
9.1. Introduction
9.2. Crow's Feet
9.3. Forehead Lines
9.4. Glabellar Lines
9.5. Hyperhidrosis
10. Botulinum Toxins in Dermatology & Cosmetology Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Dermatology Clinics
10.4. Hospitals
10.5. Medical Spas
11. Botulinum Toxins in Dermatology & Cosmetology Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Botulinum Toxins in Dermatology & Cosmetology Market, by Route Of Administration
12.1. Introduction
12.2. Intradermal Injection
12.3. Intramuscular Injection
12.4. Subcutaneous Injection
13. Americas Botulinum Toxins in Dermatology & Cosmetology Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Botulinum Toxins in Dermatology & Cosmetology Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Botulinum Toxins in Dermatology & Cosmetology Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Ipsen S.A.
16.3.3. Galderma S.A.
16.3.4. Merz Pharma GmbH & Co. KGaA
16.3.5. Daewoong Pharmaceutical Co., Ltd.
16.3.6. Evolus, Inc.
16.3.7. Medytox, Inc.
16.3.8. Revance Therapeutics, Inc.
16.3.9. HUGEL, Inc.
16.3.10. Lanzhou Institute of Biological Products
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET MULTI-CURRENCY
FIGURE 2. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ABOBOTULINUMTOXINA (DYSPORT), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INCOBOTULINUMTOXINA (XEOMIN), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY LETIBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ONABOTULINUMTOXINA (BOTOX), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRABOTULINUMTOXINA (JEUVEAU), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY RIMABOTULINUMTOXINB (MYOBLOC), BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CROW'S FEET, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FOREHEAD LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GLABELLAR LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INTRADERMAL INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 54. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 55. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 62. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 98. GERMANY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 99. GERMANY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. GERMANY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. GERMANY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. FRANCE BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. FRANCE BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 104. FRANCE BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 105. FRANCE BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 106. FRANCE BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. FRANCE BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. FRANCE BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. ITALY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. ITALY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 118. ITALY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 119. ITALY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 120. ITALY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. ITALY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. ITALY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. SPAIN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. SPAIN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 125. SPAIN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 126. SPAIN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SPAIN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SPAIN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. DENMARK BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. QATAR BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. QATAR BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 167. QATAR BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 168. QATAR BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 169. QATAR BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. QATAR BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. QATAR BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. FINLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 174. FINLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 175. FINLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 176. FINLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. FINLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. FINLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. EGYPT BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. EGYPT BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 195. EGYPT BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 196. EGYPT BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 197. EGYPT BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. EGYPT BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. EGYPT BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. TURKEY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. TURKEY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 202. TURKEY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 203. TURKEY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 204. TURKEY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. TURKEY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. TURKEY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. NORWAY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 216. NORWAY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 217. NORWAY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 218. NORWAY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. NORWAY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. NORWAY BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. POLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 223. POLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 224. POLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 225. POLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. POLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. POLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 243. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 245. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 246. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 247. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 252. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE B, 2018-2030 (USD MILLION)
TABLE 253. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 254. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. JAPAN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN TYPE A, 2018-2030 (USD MILLION)
TABLE 259. JAPAN BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Botulinum Toxins in Dermatology & Cosmetology market report include:
  • AbbVie Inc.
  • Ipsen S.A.
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Daewoong Pharmaceutical Co., Ltd.
  • Evolus, Inc.
  • Medytox, Inc.
  • Revance Therapeutics, Inc.
  • HUGEL, Inc.
  • Lanzhou Institute of Biological Products

Related Topics

Related Reports

Botulinum Toxin in Medical Cosmetology Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Botulinum Toxin in Medical Cosmetology Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Botulinum Toxin Market Overview, 2025-2030 - Product Image

Botulinum Toxin Market Overview, 2025-2030

  • Report
  • 128 Pages
  • Global
From
Botulinum Toxin & HA Dermal Filler Market by Product Type, Application Area, Indication, End User, Distribution Channel, Age Group, Gender - Global Forecast to 2030 - Product Image

Botulinum Toxin & HA Dermal Filler Market by Product Type, Application Area, Indication, End User, Distribution Channel, Age Group, Gender - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Botulinum Toxin - Global Strategic Business Report - Product Image

Botulinum Toxin - Global Strategic Business Report

  • Report
  • 353 Pages
  • Global
From
Botulinum Toxin Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Botulinum Toxin Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.